Cargando…
Clinical Efficacy, Antibiotic Resistance Genes, Virulence Factors and Outcome of Hospital-Acquired Pneumonia Induced by Klebsiella pneumoniae Carbapenemase 2-Producing with Tigecycline Treatment in the ICU
PURPOSE: Tigecycline is an agent for carbapenemase-producing Klebsiella pneumonia (KPC-KP), given its penetration into lung tissues. Our study focused on the molecular and clinical efficacy of tigecycline for hospital-acquired pneumonia (HAP) in the ICU. PATIENTS AND METHODS: A retrospective cohort...
Autores principales: | Bai, Xiang-Rong, Cao, Jing-Rong, Wang, Zhi-Zhou, Li, Wen-Chao, Chen, Dian-Dian, Lou, Ran, Qu, Xin, Yan, Su-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509680/ https://www.ncbi.nlm.nih.gov/pubmed/36168639 http://dx.doi.org/10.2147/IDR.S381280 |
Ejemplares similares
-
Efficacy of tigecycline, polymyxin, gentamicin, meropenem and associations in experimental Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae non-lethal sepsis
por: Toledo, Paula Virginia Michelon, et al.
Publicado: (2014) -
Carbapenemase-producing Klebsiella pneumoniae
por: Robilotti, Elizabeth, et al.
Publicado: (2014) -
Carbapenemase-producing Klebsiella pneumoniae intra-abdominal infection successfully treated with ceftazidime/avibactam plus tigecycline
por: Guedes, Mariana, et al.
Publicado: (2020) -
Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015) -
Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment
por: Wang, Fangzhou, et al.
Publicado: (2021)